Information Provided By:
Fly News Breaks for February 25, 2016
SIRO, XRAY
Feb 25, 2016 | 05:51 EDT
UBS analyst Steven Valiquette upgraded DENTSPLY (XRAY) to Neutral after raising his estimates to reflect accretion from the Sirona Dental (SIRO) merger. The analyst believes the $125M synergies related to the deal are "fairly straightforward" and upped his price target for DENTSPLY shares to $60 from $50.